Change in Ratings
coverage initiated at J.P.Morgan with a Neutral rating. See attractive growth profile fully valued in shares. Also note 2009 cyclical headwinds and potential increase in operating expenses to support surveillance product sales. Price target at $59.
upgraded at J.P.Morgan to Overweight from Neutral based on valuation and medium-term revenue and earnings growth expectations. Also note strong liquidity position.
Holly Energy Partners
downgraded at Goldman Sachs to Neutral from Buy based on valuation. Note that shares have outperformed sector over past 6 trading days. Price target raised to $32 from $26 based on higher target yield.
upgraded at Credit Suisse to Outperform from Neutral based on attractive risk/reward following pullback. Lowered target price to $57 from $63.
upgraded at UBS to Buy from Neutral. Price target lowered to $41 from $48. Maintains 2008 EPS estimates of $2.60.
upgraded at Jefferies to Buy from Hold. Price target raised to $32 from $28. Raised fiscal 2009 EPS estimates from $1.91 to $1.92.
upgraded at UBS to Buy from Neutral. Price target lowered to $60 from $72. 2008 EPS estimates lowered to $5.15 from $5.25.
Whole Foods Market
downgraded at Jefferies to Underperform from Buy. Price target lowered to $9.50 from $23. Maintains 2008 EPS estimates of $0.92.
upgraded at Citigroup from Hold to Buy. $30 price target. Valuation call, which offsets budget cuts at E&P firms. Company has a solid project book, and balance sheet concerns have been overblown.
upgraded at Oppenheimer to Perform. The stock is down 35% since mid-September, and the new consensus analyst estimate better reflects the difficult environment.
Stock Comments/EPS Changes
numbers lowered at UBS. 2008 EPS estimates lowered to $2.11 from $2.25. Price target lowered to $47 from $52. Maintains Buy rating.
price target trimmed at Goldman to $23 from $26 following Q3 results that were slightly below expectations. Note declining market share at
. Maintained Neutral rating.
numbers lowered at UBS. 2008 EPS estimates lowered to $0.51 from $0.54. Price target lowered to $21 from $26. Maintains Neutral rating.
This article was written by a staff member of TheStreet.com.